ResearcherSwansea UniversityNo recent work listed

Nicholas George Mowbray

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9931-0145; OpenAlex author ID A5027327470. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 3

The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study. Co-author DOI 10.1038/s41416-023-02220-2 ↗
The Impact of a Centralised Pancreatic Cancer Service: a Case Study of Wales, UK. Co-author DOI 10.1007/s11605-020-04612-8 ↗
A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection. Co-author DOI 10.1016/j.hpb.2017.12.009 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bilal A. Al-Sarireh · 2 shared papers, 2018–2022 · strength 0.28
- Paper The Impact of a Centralised Pancreatic Cancer Service: a Case Study of Wales, UK. DOI 10.1007/s11605-020-04612-8 ↗
- Paper A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer res… DOI 10.1016/j.hpb.2017.12.009 ↗
Gareth Jenkins · 1 shared paper, 2022 · strength 0.19
- Paper The Impact of a Centralised Pancreatic Cancer Service: a Case Study of Wales, UK. DOI 10.1007/s11605-020-04612-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.